Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales

Core 4 - Novartis

anonymous said:

We are living in clown world with all these layers!

Click to expand...

Right?

I’ve been here long enough where they’ve implemented a similar model, and then it reverts to “simplify” which means eliminate some of the layers to bring the “field facing” team closer to executive leadership.

The change agent currently in place will eventually leave and we will go back to a more efficient and effective organization.

Investors don’t take kindly to unneeded layers.

anonymous

May 21, 2025 at 11:55 AM

Next Reorg - Novo Nordisk

anonymous said:

No no. It’s DEI! The Good Ole Boy network is undefeated

Click to expand...

Good ole boy network is alive and thriving! Can’t be defeated unless middle management wiped out

anonymous

May 21, 2025 at 11:38 AM

Crinetics - Biotech Startups

world-class science and great people

anonymous

May 21, 2025 at 11:25 AM

Whom is provably demonstrably unethical, sleazy, and prone to horrible decisions and lazy? - Bristol-Myers Squibb

It all starts at the top with Lurch. He’s certainly not lazy, but is the epitome of everything else you mention in your headline

anonymous

May 21, 2025 at 11:23 AM

This is still a wonderful organization! - Bristol-Myers Squibb

anonymous said:

While I agree with most of the statements on this thread, these problems are not unique to BMS. You could easily replace BMS with Amgen, Pfizer, Merck…. It’s a big pharma problem.

Big pharma is overstaffed and underproductive. Therefore:
1. You can’t innovate and have to buy smaller innovative companies for the assets only. Not the actual innovators.
2. People that are slackers can “get by” by staying below radar and not pissing people off. This hurts morale.
3. People stay for a LONG time, which creates a need to be political for safety and favor. Really performing well is less important than who you know. High performers that get stuck leave. Low performers stay and hide.
4. There are definitely committed doers in middle ranks (below VP) that are rewarded enough to carry the water and stay, HOPING for a promotion someday.
5. VPs + get promoted based on politics mostly. It’s not that they’re incompetent (some are), it’s just that politics is MORE important. They then want to build their empire or, these days, at least preserve it. No incentives to rock boat or drive performance. More resentment.
6. This ultimately culminates in stagnation and company sucking. Only a great (lucky) turn of event in R&D pipeline or acquisition fixes or helps this and injects energy into company. Otherwise, layoffs and increased stress or career stagnation result.
7. People that see this and have the skills take action and leave.
8. News flash: AI will likely accelerate negative affects for staff, especially slackers with administrative or repetitive jobs. You have no idea what is coming here.

Good luck.

Click to expand...

So true. Don’t expect high performers to get promoted. A true high performer cannot be expected to get promoted because they will not be shown as high performers on their evaluations.

Politics is a skill and those without this essential skill will never see the light of the day. Groupism and conformity ensure longevity for an employee but it stifles critical thinking. Pharma has the worst managers and if you are better than your manager, you are toast. Never attempt to argue with your manager no matter how right you are.

Truth is Pharma is a money maker not a patient caretaker but the patient punchlines are a necessity. Patient caretakers are the poorest in this country making patient care a very low level job which leads to neglect. Only our Pharma executives will be able to afford the best end of life care.

There are not many Pharma companies who develop a drug from inception. It is just buy, sell and layoffs. The best will never make it because no one cares about right or wrong. All they care about are profits. Bottom line, Healthcare is a disaster.

anonymous

May 21, 2025 at 11:14 AM

Recent Posts